Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPOWER pilot trial for postmenopausal women with shoulder pain
ACTRN12626000252314Phase 3Not yet recruiting
- Sponsor
- Deakin University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of estradiol + progesterone and progesterone in rotator cuff tendinitis, Rotator cuff deficiency (RCD) and Tendinopathies (2 arms), sponsored by Deakin University. Primary endpoints: Feasibility, Drop-out number and rate and 1 more. Planned start May 2026; status: not yet recruiting.
02
Drugs
estradiol + progesteroneprogesterone
03
Conditions
rotator cuff tendinitisRotator cuff deficiency (RCD)Tendinopathies
Beyond the preview
Go deeper on ACTRN12626000252314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000252314.